# Efficacy and Safety of Levemir® Used as Basal Insulin

> **NCT01548248** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 631 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** insulin detemir
- **DRUG:** insulin aspart

## Key facts

- **NCT ID:** NCT01548248
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 631 (ACTUAL)
- **Last updated:** 2017-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01548248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01548248, "Efficacy and Safety of Levemir® Used as Basal Insulin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01548248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*